Condition: Neuropathic Pain · Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The purpose of this study is to evaluate whether Crisugabalin has similar efficacy compared to Pregabalin in reducing radiotherapy-related neuropathic pain (RRNP) in patients with head and neck cancers.
This description comes directly from the study's public registry record.
Songhua Xiao · 86+13922232774 · xiaosh@mail.sysu.edu.cn
Always discuss trial participation with your own doctor first.
| Fujian Cancer Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| Sun Yat-sen Memorial Hospital, Sun Yat-sen University | Guangzhou, Guangdong, China | Recruiting |
| Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Affillated Cancer Hospital and Institute of Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The Affiliated Brain Hospital, Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Zhongshan People's Hospital | Zhongshan, Guangdong, China | Not Yet Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, Guangxi, China | Not Yet Recruiting |
| Henan Cancer Hospital (Affiliated Cancer Hospital of ZhengzhouUniversity) | Zhengzhou, Henan, China | Not Yet Recruiting |
| Hunan Provincial People's Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Hunan Brain Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Changsha Central Hospital | Changsha, Hunan, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06766916